University of British Columbia | ClinicalTrials HQ

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis	Hemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, hematologic disorder, primary myelofibrosis	Recruiting	Phase 1 / Phase 2	2026-10-02		NCT04176198
The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial	Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms	Recruiting	Phase 3	2026-09-18		NCT04284839
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis	CNS demyelinating autoimmune disease, Chronic Disease, Disease Attributes, Multiple Sclerosis, Primary Progressive, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, chronic progressive multiple sclerosis, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder	Active, not recruiting	Phase 3	2026-09-17		NCT04544449
Parkinson's Foundation PD GENEration Genetic Registry	Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy	Recruiting	Not stated	2026-09-08		NCT04994015
Using Non-invasive Brain and Spinal Cord Stimulation to Improve Arm and Hand Function After Spinal Cord Injury	Pathologic Processes, Pathological Conditions, Signs and Symptoms, central nervous system disorder, disease, injury, nervous system disorder, nervous system injury, spinal cord disorder, spinal cord injury	Not yet recruiting	Not applicable	2026-02-20		NCT07423949